Literature DB >> 21583035

2-(3-Pyridinio)benzimidazolium penta-chloridoanti-monate(III) monohydrate.

Li-Jing Cui1, Hai-Jun Xu, Ke-Ji Pan.   

Abstract

In the title compound, (C(12)H(11)N(3))[SbCl(5)]·H(2)O, the Sb(III) centre is surrounded by five Cl atoms and displays a distorted square-pyramidal coordination geometry. The dihedral angle formed by the plane of the imidazole ring system with the pyridine ring is 4.380 (15)°. The crystal structure is stabilized by N-H⋯Cl, O-H⋯Cl and N-H⋯O hydrogen bonds, forming a three-dimensional network.

Entities:  

Year:  2009        PMID: 21583035      PMCID: PMC2969637          DOI: 10.1107/S1600536809018935

Source DB:  PubMed          Journal:  Acta Crystallogr Sect E Struct Rep Online        ISSN: 1600-5368


Related literature

For the pharmacologic activity of benzimidazole derivatives, see: Minoura et al. (2004 ▶); Pawar et al. (2004 ▶); Demirayak et al. (2002 ▶).

Experimental

Crystal data

(C12H11N3)[SbCl5]·H2O M = 514.25 Monoclinic, a = 9.2619 (19) Å b = 13.425 (3) Å c = 14.380 (3) Å β = 102.27 (3)° V = 1747.2 (7) Å3 Z = 4 Mo Kα radiation μ = 2.35 mm−1 T = 293 K 0.25 × 0.22 × 0.19 mm

Data collection

Rigaku SCXmini diffractometer Absorption correction: multi-scan (CrystalClear; Rigaku, 2005 ▶) T min = 0.892, T max = 0.964 (expected range = 0.592–0.640) 15623 measured reflections 3410 independent reflections 3037 reflections with I > 2σ(I) R int = 0.043

Refinement

R[F 2 > 2σ(F 2)] = 0.028 wR(F 2) = 0.068 S = 0.93 3410 reflections 199 parameters 6 restraints H-atom parameters constrained Δρmax = 0.32 e Å−3 Δρmin = −0.48 e Å−3 Data collection: CrystalClear (Rigaku, 2005 ▶); cell refinement: CrystalClear; data reduction: CrystalClear; program(s) used to solve structure: SHELXS97 (Sheldrick, 2008 ▶); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008 ▶); molecular graphics: SHELXTL (Sheldrick, 2008 ▶); software used to prepare material for publication: SHELXL97. Crystal structure: contains datablocks I, global. DOI: 10.1107/S1600536809018935/rz2324sup1.cif Structure factors: contains datablocks I. DOI: 10.1107/S1600536809018935/rz2324Isup2.hkl Additional supplementary materials: crystallographic information; 3D view; checkCIF report
(C12H11N3)[SbCl5]·H2OF(000) = 1000
Mr = 514.25Dx = 1.955 Mg m3
Monoclinic, P21/cMo Kα radiation, λ = 0.71073 Å
Hall symbol: -P 2ybcCell parameters from 1647 reflections
a = 9.2619 (19) Åθ = 3.0–27.6°
b = 13.425 (3) ŵ = 2.35 mm1
c = 14.380 (3) ÅT = 293 K
β = 102.27 (3)°Prism, colourless
V = 1747.2 (7) Å30.25 × 0.22 × 0.19 mm
Z = 4
Rigaku SCXmini diffractometer3410 independent reflections
Radiation source: fine-focus sealed tube3037 reflections with I > 2σ(I)
graphiteRint = 0.043
Detector resolution: 13.6612 pixels mm-1θmax = 26.0°, θmin = 3.0°
ω scansh = −11→11
Absorption correction: multi-scan (CrystalClear; Rigaku, 2005)k = −16→16
Tmin = 0.892, Tmax = 0.964l = −17→17
15623 measured reflections
Refinement on F2Primary atom site location: structure-invariant direct methods
Least-squares matrix: fullSecondary atom site location: difference Fourier map
R[F2 > 2σ(F2)] = 0.028Hydrogen site location: inferred from neighbouring sites
wR(F2) = 0.068H-atom parameters constrained
S = 0.93w = 1/[σ2(Fo2) + (0.0319P)2 + 2.5497P] where P = (Fo2 + 2Fc2)/3
3410 reflections(Δ/σ)max = 0.001
199 parametersΔρmax = 0.32 e Å3
6 restraintsΔρmin = −0.47 e Å3
Geometry. All e.s.d.'s (except the e.s.d. in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell e.s.d.'s are taken into account individually in the estimation of e.s.d.'s in distances, angles and torsion angles; correlations between e.s.d.'s in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell e.s.d.'s is used for estimating e.s.d.'s involving l.s. planes.
Refinement. Refinement of F2 against ALL reflections. The weighted R-factor wR and goodness of fit S are based on F2, conventional R-factors R are based on F, with F set to zero for negative F2. The threshold expression of F2 > σ(F2) is used only for calculating R-factors(gt) etc. and is not relevant to the choice of reflections for refinement. R-factors based on F2 are statistically about twice as large as those based on F, and R- factors based on ALL data will be even larger.
xyzUiso*/Ueq
Sb10.98691 (2)0.410246 (16)0.112742 (15)0.02964 (9)
Cl10.98813 (10)0.24807 (7)0.17778 (7)0.0451 (2)
Cl21.06091 (10)0.48665 (7)0.29163 (6)0.0446 (2)
Cl30.93983 (10)0.34774 (8)−0.06139 (6)0.0445 (2)
Cl41.25689 (10)0.38926 (8)0.11321 (8)0.0516 (3)
Cl50.68651 (10)0.39170 (8)0.09585 (6)0.0434 (2)
C10.5091 (3)0.3717 (2)0.4685 (2)0.0280 (7)
C20.4622 (4)0.3711 (3)0.3703 (2)0.0346 (7)
H2A0.36310.36420.34090.042*
C30.5715 (4)0.3813 (3)0.3187 (3)0.0412 (9)
H3A0.54570.38040.25260.049*
C40.7199 (4)0.3929 (3)0.3638 (3)0.0463 (10)
H4A0.79010.39890.32650.056*
C50.7658 (4)0.3958 (3)0.4611 (3)0.0433 (9)
H5A0.86460.40460.49050.052*
C60.6566 (4)0.3849 (2)0.5131 (2)0.0304 (7)
C70.5252 (3)0.3714 (2)0.6244 (2)0.0280 (7)
C80.4838 (4)0.3694 (2)0.7169 (2)0.0289 (7)
C90.5913 (4)0.3773 (3)0.7992 (2)0.0376 (8)
H9A0.69060.38120.79630.045*
N30.5509 (4)0.3794 (2)0.8830 (2)0.0421 (7)
H3B0.61900.38410.93380.051*
C110.4115 (5)0.3745 (3)0.8920 (3)0.0417 (9)
H11A0.38910.37760.95200.050*
C120.3373 (4)0.3627 (3)0.7250 (2)0.0364 (8)
H12A0.26300.35660.67050.044*
N10.4320 (3)0.3631 (2)0.54084 (18)0.0285 (6)
H1A0.33830.35380.53280.034*
N20.6611 (3)0.3840 (2)0.6097 (2)0.0335 (6)
H2B0.73960.39050.65360.040*
C100.3011 (4)0.3649 (3)0.8128 (3)0.0407 (8)
H10A0.20310.35990.81820.049*
O1W0.1429 (3)0.3470 (2)0.4754 (2)0.0636 (9)
H1WA0.12600.38920.43030.076*
H1WB0.09510.29250.46760.076*
U11U22U33U12U13U23
Sb10.02958 (13)0.02996 (14)0.02782 (13)−0.00150 (9)0.00262 (9)0.00183 (9)
Cl10.0391 (5)0.0362 (5)0.0563 (6)−0.0002 (4)0.0014 (4)0.0136 (4)
Cl20.0442 (5)0.0505 (5)0.0366 (5)−0.0094 (4)0.0033 (4)−0.0069 (4)
Cl30.0465 (5)0.0524 (6)0.0302 (4)0.0073 (4)−0.0016 (4)−0.0029 (4)
Cl40.0338 (5)0.0687 (7)0.0536 (6)−0.0061 (4)0.0121 (4)−0.0013 (5)
Cl50.0362 (5)0.0638 (6)0.0294 (4)0.0076 (4)0.0051 (4)−0.0009 (4)
C10.0268 (16)0.0268 (16)0.0303 (17)−0.0023 (13)0.0056 (13)0.0006 (13)
C20.0346 (18)0.0373 (19)0.0307 (17)−0.0029 (15)0.0042 (14)0.0015 (15)
C30.050 (2)0.041 (2)0.0347 (19)0.0018 (17)0.0125 (17)0.0028 (16)
C40.043 (2)0.052 (2)0.050 (2)0.0057 (18)0.0234 (19)0.0063 (18)
C50.0252 (18)0.054 (2)0.052 (2)0.0025 (16)0.0107 (16)−0.0012 (18)
C60.0258 (16)0.0304 (17)0.0345 (18)0.0018 (13)0.0051 (14)0.0005 (14)
C70.0243 (16)0.0278 (16)0.0296 (17)−0.0012 (13)0.0003 (13)0.0004 (13)
C80.0297 (16)0.0262 (16)0.0284 (16)−0.0001 (13)0.0011 (13)0.0001 (13)
C90.0345 (19)0.042 (2)0.0316 (18)−0.0054 (15)−0.0032 (15)−0.0015 (15)
N30.0470 (19)0.0465 (19)0.0260 (15)−0.0043 (14)−0.0073 (13)−0.0020 (13)
C110.056 (2)0.039 (2)0.0301 (19)−0.0013 (17)0.0093 (17)−0.0027 (16)
C120.0316 (18)0.043 (2)0.0312 (18)−0.0028 (15)−0.0005 (14)0.0018 (15)
N10.0199 (13)0.0392 (16)0.0252 (13)−0.0065 (11)0.0026 (10)0.0025 (12)
N20.0215 (13)0.0430 (17)0.0331 (15)−0.0011 (12)−0.0008 (11)−0.0007 (13)
C100.039 (2)0.048 (2)0.0365 (19)−0.0003 (17)0.0103 (16)−0.0029 (17)
O1W0.0352 (15)0.074 (2)0.073 (2)−0.0205 (14)−0.0072 (14)0.0269 (17)
Sb1—Cl12.3687 (10)C7—N11.327 (4)
Sb1—Cl42.5149 (11)C7—C81.461 (4)
Sb1—Cl32.5885 (10)C8—C91.379 (5)
Sb1—Cl22.7184 (11)C8—C121.389 (5)
Sb1—Cl52.7522 (11)C9—N31.336 (5)
C1—C21.386 (5)C9—H9A0.9300
C1—N11.387 (4)N3—C111.327 (5)
C1—C61.391 (4)N3—H3B0.8600
C2—C31.383 (5)C11—C101.365 (5)
C2—H2A0.9300C11—H11A0.9300
C3—C41.398 (6)C12—C101.374 (5)
C3—H3A0.9300C12—H12A0.9300
C4—C51.374 (6)N1—H1A0.8600
C4—H4A0.9300N2—H2B0.8600
C5—C61.388 (5)C10—H10A0.9300
C5—H5A0.9300O1W—H1WA0.8501
C6—N21.381 (4)O1W—H1WB0.8499
C7—N21.331 (4)
Cl1—Sb1—Cl488.55 (4)N2—C7—N1108.8 (3)
Cl1—Sb1—Cl393.99 (4)N2—C7—C8126.0 (3)
Cl4—Sb1—Cl385.94 (4)N1—C7—C8125.2 (3)
Cl1—Sb1—Cl289.66 (4)C9—C8—C12118.3 (3)
Cl4—Sb1—Cl289.38 (4)C9—C8—C7119.8 (3)
Cl3—Sb1—Cl2173.98 (3)C12—C8—C7121.8 (3)
Cl1—Sb1—Cl582.62 (3)N3—C9—C8119.0 (3)
Cl4—Sb1—Cl5167.42 (4)N3—C9—H9A120.5
Cl3—Sb1—Cl585.76 (4)C8—C9—H9A120.5
Cl2—Sb1—Cl599.46 (4)C11—N3—C9123.5 (3)
C2—C1—N1131.6 (3)C11—N3—H3B118.2
C2—C1—C6122.4 (3)C9—N3—H3B118.2
N1—C1—C6106.0 (3)N3—C11—C10119.7 (3)
C3—C2—C1116.0 (3)N3—C11—H11A120.2
C3—C2—H2A122.0C10—C11—H11A120.2
C1—C2—H2A122.0C10—C12—C8120.6 (3)
C2—C3—C4121.5 (4)C10—C12—H12A119.7
C2—C3—H3A119.3C8—C12—H12A119.7
C4—C3—H3A119.3C7—N1—C1109.4 (3)
C5—C4—C3122.4 (4)C7—N1—H1A125.3
C5—C4—H4A118.8C1—N1—H1A125.3
C3—C4—H4A118.8C7—N2—C6109.5 (3)
C4—C5—C6116.2 (3)C7—N2—H2B125.3
C4—C5—H5A121.9C6—N2—H2B125.3
C6—C5—H5A121.9C11—C10—C12118.9 (4)
N2—C6—C5132.3 (3)C11—C10—H10A120.5
N2—C6—C1106.3 (3)C12—C10—H10A120.5
C5—C6—C1121.4 (3)H1WA—O1W—H1WB117.8
D—H···AD—HH···AD···AD—H···A
N1—H1A···O1W0.861.822.652 (4)161
N3—H3B···Cl5i0.862.283.056 (3)150
N2—H2B···Cl2ii0.862.483.179 (3)139
O1W—H1WA···Cl2iii0.852.353.197 (3)172
O1W—H1WB···Cl3iv0.852.353.198 (3)174
Table 1

Hydrogen-bond geometry (Å, °)

D—H⋯AD—HH⋯ADAD—H⋯A
N1—H1A⋯O1W0.861.822.652 (4)161
N3—H3B⋯Cl5i0.862.283.056 (3)150
N2—H2B⋯Cl2ii0.862.483.179 (3)139
O1W—H1WA⋯Cl2iii0.852.353.197 (3)172
O1W—H1WB⋯Cl3iv0.852.353.198 (3)174

Symmetry codes: (i) ; (ii) ; (iii) ; (iv) .

  4 in total

1.  A short history of SHELX.

Authors:  George M Sheldrick
Journal:  Acta Crystallogr A       Date:  2007-12-21       Impact factor: 2.290

2.  Synthesis and anticancer and anti-HIV testing of some pyrazino[1,2-a]benzimidazole derivatives.

Authors:  Seref Demirayak; Usama Abu Mohsen; Ahmet Cağri Karaburun
Journal:  Eur J Med Chem       Date:  2002-03       Impact factor: 6.514

3.  Studies of antimicrobial activity of N-alkyl and N-acyl 2-(4-thiazolyl)-1H-benzimidazoles.

Authors:  N S Pawar; D S Dalal; S R Shimpi; P P Mahulikar
Journal:  Eur J Pharm Sci       Date:  2004-02       Impact factor: 4.384

4.  Pharmacological characteristics of a novel nonthiazolidinedione insulin sensitizer, FK614.

Authors:  Hideaki Minoura; Shigeru Takeshita; Makoto Ita; Jiro Hirosumi; Miyuki Mabuchi; Ikuo Kawamura; Satoko Nakajima; Osamu Nakayama; Hiroshi Kayakiri; Teruo Oku; Akiko Ohkubo-Suzuki; Masao Fukagawa; Hitoshi Kojo; Kenichi Hanioka; Noritsugu Yamasaki; Takafumi Imoto; Yoshinori Kobayashi; Seitaro Mutoh
Journal:  Eur J Pharmacol       Date:  2004-06-28       Impact factor: 4.432

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.